批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/06/20 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/11/02 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/09/20 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/08/24 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/12/01 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/07/28 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/05/16 |
SUPPL-27(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/11/14 |
SUPPL-26(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/02/05 |
SUPPL-25(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2002/06/17 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1998/07/15 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/06/25 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1995/08/30 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1993/08/06 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1992/05/07 |
SUPPL-15(补充) |
Approval |
Labeling |
|
|
|
1991/09/06 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1954/11/16 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:DIGOXIN 剂型/给药途径:INJECTABLE;INJECTION 规格:0.25MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
009330 |
002 |
NDA |
LANOXIN |
DIGOXIN |
INJECTABLE;INJECTION |
0.25MG/ML |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
COVIS |
083391 |
001 |
ANDA |
DIGOXIN |
DIGOXIN |
INJECTABLE;INJECTION |
0.25MG/ML |
Prescription |
No |
No |
AP |
Approved Prior to Jan 1, 1982
|
HIKMA |
040481 |
001 |
ANDA |
DIGOXIN |
DIGOXIN |
INJECTABLE;INJECTION |
0.25MG/ML |
Prescription |
No |
No |
AP |
2003/08/21
|
SANDOZ |